Correlation of circulating PD-L2 levels with outcomes of therapy with the anti-PD-1 antibody pembrolizumab (P) in patients (pts) with advanced soft tissue sarcomas (STS): Biomarker analysis of SARC028.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Burgess, MA; Roszik, J; Van Tine, BA; Hu, J; Schuetze, S; D'Angelo, SP; Attia, S; Priebat, DA; Okuno, SH; Riedel, RF; Davis, LE; Movva, S; Reed, DR; Baker, LH; Reinke, DK; Maki, RG; Patel, S; Tawbi, HA-H; Butterfield, LH

Published Date

  • March 1, 2017

Published In

Volume / Issue

  • 35 / 7

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET

Conference Location

  • Chicago, IL

Conference Start Date

  • June 2, 2017

Conference End Date

  • June 7, 2017